Literature DB >> 30903638

Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017.

Shigehisa Fumino1, Tatsuro Tajiri1, Noriaki Usui2, Masanori Tamura3, Haruhiko Sago4, Shigeru Ono5, Shunsuke Nosaka6, Akihiro Yoneda7, Ryota Souzaki8, Mayumi Higashi1, Kohei Sakai1, Ken Takahashi9, Takahiro Sugiura10, Tomoaki Taguchi8.   

Abstract

BACKGROUND: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT.
METHODS: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus.
RESULTS: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications.
CONCLUSIONS: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.
© 2019 Japan Pediatric Society.

Entities:  

Keywords:  guideline; long-term prognosis; risk factor; sacrococcygeal teratoma

Year:  2019        PMID: 30903638     DOI: 10.1111/ped.13844

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Clinicopathological Evaluation of Childhood Sacrococcygeal Germ Cell Tumors: A Single-Center Experience.

Authors:  Bermal Hasbay; Tuba Canpolat; Elif Aktekin; Hasan Özkan; Şenay Demir Kekeç
Journal:  Turk Arch Pediatr       Date:  2022-05

2.  Sacrococcygeal Teratoma : A Tumor at the Center of Embryogenesis.

Authors:  Ji Hoon Phi
Journal:  J Korean Neurosurg Soc       Date:  2021-04-29

3.  Epidemiological characteristics of 1385 primary sacral tumors in one institution in China.

Authors:  Jun Wang; Dasen Li; Rongli Yang; Xiaodong Tang; Taiqiang Yan; Wei Guo
Journal:  World J Surg Oncol       Date:  2020-11-12       Impact factor: 2.754

4.  A Clinical Analysis of the Diagnosis and Treatment of Fetal Sacrococcygeal Teratomas.

Authors:  Xiu-Qiong Zheng; Rong-Li Xu; Jian-Ying Yan; Xue-Chun Wang; Xian Chen; Ke-Hua Huang
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

5.  Factors associated with poor outcome in fetuses prenatally diagnosed with sacrococcygeal teratoma.

Authors:  Lieke J van Heurn; Audrey B C Coumans; Joep P M Derikx; Mireille N Bekker; Katia M Bilardo; Leonie K Duin; Maarten F C M Knapen; Eva Pajkrt; Esther Sikkel; L W Ernest van Heurn; Dick Oepkes
Journal:  Prenat Diagn       Date:  2021-08-05       Impact factor: 3.242

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.